<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                                                                                                                                    Article <br />  <br />                                                                                                                              pubs.acs.org/biochemistry <br />  <br />  <br />  <br />  <br /> Mechanism Feedback Allosteric Inhibition <span id='am-27' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-28' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-29' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-34' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span>ATP</span> <br /> Phosphoribosyltransferase nia Pedren&#204;&#402;o,&#226;&#8364;&#160; Joao&#204;&#402; Pedro Pisco,&#226;&#8364;&#160; Ge&#204;?rald Larrouy-Maumus,&#226;&#8364;&#160; Geo&#239;&#172;&#8364; Kelly,&#226;&#8364;&#161; Luiz Pedro ?rio Carvalho*,&#226;&#8364;&#160; <br /> &#226;&#8364;&#160; <br /> Mycobacterial Research Division, MRC National Institute Medical Research, &#226;&#8364;&#161;MRC Biomolecular NMR Centre, Ridgeway, Hill, London NW7 1AA, U.K. <br />  <br />  <br />  <br />  <br />     ABSTRACT: MtATP-phosphoribosyltransferase catalyzes &#239;&#172;?rst committed step <span id='am-17' about='obo:IMR_0200137' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0001695 obo:IMR_0000001'><span id='am-18' property="oboInOwl:hasDbXref" content="KEGG:C00135" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="L-Histidine" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:id" content="IMR:0200137" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>L-histidine</span> biosynthesis     Mycobacterium tuberculosis subjected allosteric feedback regulation. essentiality, enzyme <br />     studied potential target novel anti-infectives. understand basis regulation, characterized     allosteric inhibition using gel &#239;&#172;?ltration, steady-state pre-steady-state kinetics, pH dependence inhibition     binding. Gel &#239;&#172;?ltration experiments indicate MtATP-phosphoribosyltransferase hexamer solution, presence     absence L-histidine. Steady-state kinetic studies demonstrate L-histidine inhibition uncompetitive versus ATP     noncompetitive versus PRPP. pH values close neutrality, Kii value 4 &#206;&#188;M obtained L-histidine. Pre-steady-state <br />     kinetic experiments indicate chemistry rate-limiting overall reaction L-histidine inhibition caused     trapping enzyme inactive conformation. pH dependence binding, obtained nuclear magnetic resonance, <br />     indicates L-histidine binds better neutral &#206;&#177;-amino group. pH dependence inhibition (Kii), contrary, <br />     indicates L-histidine better inhibits MtATP-phosphoribosytransferase neutral imidazole ionized &#206;&#177;-amino <br />     group. results combined model accounts allosteric inhibition MtATP-phosphoribosyltransferase. <br />  <br />  <br />                                                                             active site enzyme deemed  targetable&#226;&#8364;? poor <br /> F    eedback allosteric inhibition metabolic enzymes      e&#239;&#172;&#402;cient mechanisms maintained evolution control &#239;&#172;&#8218;ux biochemical pathways.1&#226;&#710;&#8217;3 <br />                                                                             &#226;&#8364;&#339;ligandability&#226;&#8364;?.7,8 examples important enzymes                                                                             successfully targeted allosteric site pyruvate <br /> E&#239;&#172;&#402;ciency comes direct, speci&#239;&#172;?c, nearly instanta-                 kinase  potential antihyperglycemic therapy),9 mitotic <br /> neous e&#239;&#172;&#8364;ect, permits dynamic control &#239;&#172;&#8218;ux               kinesin (involved centrosome separation formation biochemical pathways. addition, feedback inhibition                   bipolar mitotic spindle),10 Staphylococcus aureus D- <br /> independent transcription, translation, intricate signal             alanine:D-alanine ligase (involved <span id='am-61' about='obo:IMR_0001699' typeof='owl:Thing obo:IMR_0001790 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0000001 obo:IMR_0001700'><span id='am-62' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-63' property="obo:IAO_0000115" content="Peptidoglycan (PGN) is a unique and essential component of the cell wall of virtually all bacteria, is not present in eukaryotes, and is an excellent target for the innate immune system." datatype="xsd:string"></span><span id='am-64' property="oboInOwl:id" content="IMR:0001699" datatype="xsd:string"></span><span id='am-65' property="oboInOwl:hasDbXref" content="KEGG:C00889" datatype="xsd:string"></span><span id='am-66' property="oboInOwl:hasExactSynonym" content="murein" datatype="xsd:string"></span><span id='am-67' property="rdfs:label" content="murein" datatype="xsd:string"></span><span id='am-68' property="oboInOwl:hasExactSynonym" content="PGN" datatype="xsd:string"></span><span id='am-69' property="rdfs:label" content="PGN" datatype="xsd:string"></span><span id='am-70' property="rdfs:label" content="peptidoglycan" datatype="xsd:string"></span><span id='am-71' property="oboInOwl:hasDbXref" content="MeSH:D010457" datatype="xsd:string"></span>peptidoglycan</span> biosyn- <br /> transduction cascades.                                                      thesis),11 Cdc34 ubiquitin-conjugatin enzyme (active <br />    Natural feedback inhibitors serve templates              certain prostate colorectal cancer cell lines),12 chemically diverse, allosteric small molecule inhibitors,             Haemophilus inf luenzae HslUV protease  bacterial version currently intensely sought probes <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="chemical" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>chemical</span> biology               proteosome).13 chemical genetics, regulators synthetic biology,                remarkable example allosterically regulated enzyme therapeutics diseases. addition qualities          ATP phosphoribosyltransferase (ATP-PRT), encoded described  allosteric inhibitors display                  hisG gene Mycobacterium tuberculosis. MtATP-PRT catalyzes <br /> appealing features small molecule therapeutics. instance,            &#239;&#172;?rst committed step L-histidine biosynthesis (Scheme 1) <br /> allosteric inhibitors potential noncompetitive            inhibited end product pathway, L- <br /> uncompetitive versus particular substrate4 time-depend- <br /> ent5,6 target sites enzyme active              Received: June 18, 2012 <br /> site. reasons, allosteric inhibitors target              Revised: August 22, 2012 <br /> feedback site compounds choice                     Published: September 18, 2012 <br />  <br />                                &#194;&#169; 2012 American Chemical Society      8027                       dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                        Article <br />  <br /> Scheme 1                                                                   validation, e., essentiality reaction pathway <br />                                                                            M. tuberculosis, con&#239;&#172;?rmed high-resolution <br />                                                                            transposon mutagenesis18 clean genetic knockouts                                                                            enzymes pathway.19 addition, pathway absent                                                                            humans, suggests priori toxicity associated                                                                            potential inhibitors. <br />                                                                               ATP-PRTs (EC 2.4.2.17) catalyze reversible, Mg2+- <br />                                                                            dependent formation 1-(5-phospho-&#206;&#177;-D-ribosyl)-ATP (PR- <br />                                                                            ATP) inorganic <span id='am-5' about='obo:IMR_0200280' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-6' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:id" content="IMR:0200280" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasDbXref" content="KEGG:C00013" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="Pyrophosphate" datatype="xsd:string"></span>pyrophosphate</span> (PPi) ATP 5- <br />                                                                            phospho-&#206;&#177;-D-ribosyl pyrophosphate (PRPP) (Scheme 2). <br />                                                                            ATP-PRTs activated K+.20 reaction <br />                                                                            shown proceed directly, generation                                                                            covalent intermediate,21 follow sequential ordered <br />                                                                            kinetic mechanism ATP &#239;&#172;?rst substrate bind                                                                            PR-ATP product dissociate.22 Interestingly, ATP- <br />                                                                            PRT anthranilate-PRT phosphoribosyltrans- <br />                                                                            ferases (PRTs) described day involved                                                                            <span id='am-56' about='obo:IMR_0001697' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-57' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-58' property="rdfs:label" content="nucleoside" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:hasDbXref" content="CHEBI:25611" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:id" content="IMR:0001697" datatype="xsd:string"></span>nucleoside</span> NAD+/NADP+ metabolism. Common ribosyl <br />                                                                            acceptors used PRTs orotate, <span id='am-72' about='obo:IMR_0200025' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-73' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-74' property="oboInOwl:id" content="IMR:0200025" datatype="xsd:string"></span><span id='am-75' property="oboInOwl:hasDbXref" content="KEGG:C00153" datatype="xsd:string"></span><span id='am-76' property="rdfs:label" content="Nicotinamide" datatype="xsd:string"></span>nicotinamide</span>/ <br />                                                                            nicotinate, <span id='am-22' about='obo:IMR_0200350' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-23' property="oboInOwl:id" content="IMR:0200350" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasDbXref" content="KEGG:C00147" datatype="xsd:string"></span><span id='am-26' property="rdfs:label" content="Adenine" datatype="xsd:string"></span>adenine</span>, <span id='am-77' about='obo:IMR_0200173' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-78' property="oboInOwl:hasDbXref" content="KEGG:C00262" datatype="xsd:string"></span><span id='am-79' property="rdfs:label" content="Hypoxanthine" datatype="xsd:string"></span><span id='am-80' property="oboInOwl:id" content="IMR:0200173" datatype="xsd:string"></span><span id='am-81' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>hypoxanthine</span>/<span id='am-82' about='obo:IMR_0200319' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-83' property="rdfs:label" content="Guanine" datatype="xsd:string"></span><span id='am-84' property="oboInOwl:hasDbXref" content="KEGG:C00242" datatype="xsd:string"></span><span id='am-85' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-86' property="oboInOwl:id" content="IMR:0200319" datatype="xsd:string"></span>guanine</span>. <br />                                                                               regard tertiary quaternary structure,                                                                            types ATP-PRTs. widespread <br />                                                                            homohexameric form, encountered bacteria, fungi,                                                                            plants, hetero-octameric form, restricted                                                                            bacteria. MtATP-PRT belongs homohexameric class,16 <br />                                                                            Salmonella enterica Escherichia <br />                                                                            coli.23,24 Crystallographic data suggested MtATP-PRT                                                                            active dimer associates inactive hexamer, L- <br />                                                                            histidine binding.16 addition, L-histidine-bound hexame- <br />                                                                            ric form displays major conformational change, twist                                                                            domain III relative domains II. Crystallographic studies <br />                                                                            revealed L-histidine binds site &#226;&#710;&#188;30 &#195;&#8230;                                                                            active site, con&#239;&#172;?rming inhibition allosteric nature. <br />                                                                            Finally, shown L-histidine held allosteric site <br />                                                                            interactions carboxyl group Asp218,                                                                            hydroxyl Thr238, backbone amide oxygen                                                                            Ala273.16 <br />                                                                               L-histidine&#226;&#8364;&#8482;s imidazole group displays pKa near <br />                                                                            neutrality (&#226;&#710;&#188;6.0), de&#239;&#172;?ne ionic form <br />                                                                            binds inhibits MtATP-PRT. question                                                                            partially answered homologous enzymes S. enterica <br />                                                                            (SeATP-PRT) Corynebacterium glutamicum (CgATP- <br />                                                                            PRT).23,25 SeATP-PRT, L-histidine shown inhibit <br />                                                                            better higher pH values, indicating imidazole ring                                                                            deprotonated. contrast, CgATP-PRT, lower pH values <br />                                                                            increased potency, suggesting protonated imidazole form <br />                                                                            inhibits better. Unfortunately, studies used &#226;&#8364;&#339;IC50&#226;&#8364;? &#226;&#8364;&#339;% <br />                                                                            activity&#226;&#8364;? surrogates a&#239;&#172;&#402;nity, instead Ki Kd values, <br />                                                                            making interpretation results di&#239;&#172;&#402;cult. Currently,                                                                            information ionic state L-histidine inhibition                                                                            MtATP-PRT available. <br />                                                                               work, detailed characterization                                                                            mechanism allosteric inhibition MtATP-PRT L- <br />                                                                            histidine. use combination steady-state pre- <br />                                                                            steady-state kinetics, pH studies, 1H NMR spectroscopy,                                                                            gel &#239;&#172;?ltration experiments characterize L-histidine <br />                                                                            allosterically controls MtATP-PRT. results combined <br />                                                                            structural data available generate new model                                                                            accounts inhibition. <br /> histidine.14,15 M. tuberculosis, hisG gene predicted share operon enzyme pathway, encoded hisE gene. MtATP-PRT proposed potential <br />                                                                            &#226;&#8211;&#160;  MATERIALS METHODS <br />                                                                              Materials. Bu&#239;&#172;&#8364;ers purchased Fisher Scienti&#239;&#172;?c. <br /> target development novel anti-TB agents.16,17 Target            Unless stated, chemicals purchased <br />                                                                     8028                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                       Article <br />  <br /> Scheme 2 <br />  <br />  <br />  <br />  Sigma-Aldrich. Baker&#226;&#8364;&#8482;s yeast inorganic pyrophosphatase                   pre-steady-state kinetic experiments, larger purchased Sigma-Aldrich. M. tuberculosis inorganic                amounts inorganic pyrophosphatase required, used <br /> pyrophosphatase (Rv3628) produced laboratory (L.                recombinant inorganic pyrophosphatase M. tuberculosis <br /> P. Carvalho, unpublished results). Chromatographic columns                 produced laboratory (L. P. Carvalho, unpublished purchased GE, Ni-NTA resin purchased                     results). EMD. Complete EDTA-Free protease inhibitor                           Gel Filtration. solution oligomeric state MtATP- <br /> purchased Roche. BL21(DE3)pLysS EMD.                         PRT determined using Sephacryl S-200 column    General Methods Equipment. protein concen-                      molecular weight standards (Bio-Rad). Typically, 100 &#206;&#188;L tration measured using BCA assay Pierce, using                MtATP-PRT concentrations ranging 0.1 10 mg/mL <br /> bovine serum albumin standard. Protein puri&#239;&#172;?cation                injected. Protein eluted isocratically 1.5 column <br /> performed using AKTA puri&#239;&#172;?er 10 (GE Healthcare). SDS&#226;&#710;&#8217;                   volumes, rate 0.5 mL/min. bu&#239;&#172;&#8364;er 20 mM Tris- <br /> PAGE performed PhastSystem (GE Healthcare).                       HCl (pH 8) containing 100 mM NaCl, 2 mM <br /> Spectrophotometry conducted Shimadzu UV-2550                    L-histidine. <br /> spectrophotometer equipped dual-beam optics                        Measurement Enzymatic Activity. Initial velocities Peltier temperature control. Stopped-&#239;&#172;&#8218;ow absorb-                forward reaction MtATP-PRT measured ance spectroscopy conducted Applied Photophysics                 following formation PR-ATP (&#206;&#181;290 = 3600 M&#226;&#710;&#8217;1 <br /> SX-20 stopped-&#239;&#172;&#8218;ow spectrophotometer, equipped                       cm&#226;&#710;&#8217;1),26 presence inorganic pyrophosphatase. <br /> circulating water bath. conditions, dead time              Pyrophosphatase essential assay, equilibrium estimated 3 ms. Experiments conducted                    constant lies formation ATP PRPP. typical <br /> mixing equal volumes solutions, containing enzyme               reaction mixture contained 50 mM Tris-HCl (pH 8.5), 7 mM variable substrate L-histidine.          MgCl2, 200 mM KCl, 800 &#206;&#188;M ATP, 400 &#206;&#188;M PRPP, 3 milliunits <br /> NMR experiments conducted using Varian Inova                        pyrophosphatase, 150 nM MtATP-PRT. activity <br /> spectrometer 14.4 T. assays conducted 25 &#194;&#176;C.            assays performed 25 &#194;&#177; 0.2 &#194;&#176;C. <br />                                                                               1 <br /> concentrations MtATP-PRT reported &#239;&#172;?nal                               H NMR Spectroscopy. dimensional spectra L- <br />                                                                            histidine function pH recorded using excitation <br /> concentrations used, monomer. <br />                                                                            sculpting27 water suppression. STD spectra recorded <br />    Plasmid Preparation, Protein Expression, Puri&#239;&#172;?- <br />                                                                            interleaved manner range saturation times (0.2&#226;&#710;&#8217; <br /> cation. Rv2121c gene sequence M. tuberculosis <br />                                                                            2.0 s 0.2 s intervals) resonance presaturation H37Rv codon adapted E. coli, <span id='am-43' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-44' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-47' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-48' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span>nucleotide</span> <br />                                                                            enzyme 0.8 ppm. single o&#239;&#172;&#8364;-resonance control spectrum <br /> sequence synthetically prepared ligated pJ411 <br />                                                                            recorded saturation time 2 s. Water suppression <br /> plasmid (DNA 2.0). DNA sequence con&#239;&#172;?rmed                            achieved excitation sculpting. Data processing, spectral <br /> sequencing. construct contained noncleavable N-                     subtractions, quantitation performed using VNMRJ <br /> terminal hexahistidine tag facilitate puri&#239;&#172;?cation. N-               1.1D. physical basis saturation transfer di&#239;&#172;&#8364;erence NMR <br /> terminal hexahistidine tag shown a&#239;&#172;&#8364;ect structure            described 28,29 activity MtATP-PRT.16                                                   Inhibition Studies. determine inhibition constants    MtATP-PRT puri&#239;&#172;?cation, steps performed               inhibition patterns associated L-histidine, MtATP-PRT <br /> 4 &#194;&#176;C. Frozen BL21(DE3)pLysS (pJ411::hisG) cells                       activity studied presence variable concentrations <br /> thawed ice, lysed sonication, presence                 substrate, &#239;&#172;?xed saturating concentrations bu&#239;&#172;&#8364;er [20 mM triethanolamine (TEA) (pH 7.8), 300 mM                      substrate metals, &#239;&#172;?xed concentrations L- <br /> NaCl, 50 mM imidazole] containing lysozyme                         histidine. <br /> Complete EDTA-free protease inhibitor cocktail. Soluble                       pH Studies. determine e&#239;&#172;&#8364;ect pH protein obtained centrifugation 25000g 30 min.               inhibitory activity L-histidine, MtATP-PRT activity soluble fraction loaded 50 mL Ni-NTA column                 studied presence variable concentrations ATP, &#239;&#172;?xed protein separated gradient using bu&#239;&#172;&#8364;er B [20 mM               saturating concentrations PRPP metals, &#239;&#172;?xed <br /> TEA (pH 7.8), 300 mM NaCl, 500 mM imidazole]. Peak                     concentrations L-histidine, di&#239;&#172;&#8364;erent pHs ranging 6.5 <br /> fractions analyzed SDS&#226;&#710;&#8217;PAGE. Fractions containing                  9.5  HEPES, PIPES, TAPS, CHES bu&#239;&#172;&#8364;ers). MtATP-PRT pooled  concentrated, dialyzed                narrow pH range MtATP-PRT, inhibition 20 mM TEA (pH 7.8), stored 50% glycerol &#226;&#710;&#8217;20 &#194;&#176;C                data pH 8 9.25 analyzed (TAPS pH 8.0  alternatively, stored &#226;&#710;&#8217;80 &#194;&#176;C &#239;&#172;&#8218;ash-frozen             8.75 CHES pH 9.0 9.25). pH 8 9.25, <br /> liquid nitrogen. protocol allowed puri&#239;&#172;?cation                  PRPP concentrations tested shown saturating. <br /> homogeneity 114 mg MtATP-PRT 15 g wet cell                      Pre-Steady-State Kinetics. Photomultiplier voltage pellet. Puri&#239;&#172;?ed ATP-PRT analyzed electrospray                       zeroed bu&#239;&#172;&#8364;er. cell 10 mm path length used <br /> ionization mass spectrometry (ESI-MS) con&#239;&#172;?rm protein                    experiments. experiments performed 25 &#194;&#176;C identity (NIMR Mass Spectrometry Facility).                                50 mM Tris-HCl (pH 8.5) containing 150 mM KCl, 10 mM <br />                                                                     8029                       dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                          Article <br />  <br /> MgCl2, 1.5 mM PRPP, 60 &#206;&#188;M pyrophosphatase, 10 &#206;&#188;M                                       &#226;&#381;&#161;                                                    &#226;&#381;&#164; <br /> MtATP-PRT. Higher concentrations substrates metals                                 { <br />                                                                                  = max &#226;&#381;&#163;E + S + Kdapp &#226;&#710;&#8217;              (E + S + Kdapp)2 &#226;&#710;&#8217; 4ES &#226;&#381;&#166; used, precipitation. Typically, 10 progress <br /> curves 1000 points averaged data                           /(2E)} <br />                                                                                                                                                             (8) <br /> &#239;&#172;?t. Rates amplitudes obtained &#239;&#172;?tting average burst equation (eq 7). Mixing achieved rapid                      Amax amplitude maximum, E concentration <br /> combination 60 &#206;&#188;L syringe. e&#239;&#172;&#8364;ect                         enzyme, S total concentration ATP, Kapp <br />                                                                                                                                       d increasing concentrations ATP  0.025 4 mM) L-                 apparent dissociation constant ATP. Similarly, histidine  5 80 &#206;&#188;M) rate reaction                  dependence kobs ATP concentration conditions <br /> measured monitoring conversion ATP PR-ATP,                   substrate enzyme concentrations comparable observing increase absorbance 290 nm.                              &#239;&#172;?t eq 9 <br />    Data Analysis. Steady-state NMR data &#239;&#172;?t using <br />                                                                                                 &#226;&#381;&#161; nonlinear, squares, curve-&#239;&#172;?tting programs Sigma- <br /> Plot Windows, version 11.0. Pre-steady-state data &#239;&#172;?t <br />                                                                                              { <br />                                                                                  kobs = k burst &#226;&#381;&#163;E + S + Kdapp <br />  <br /> using KinTek Global Kinetic Explorer,30,31 version 3.0.                                                             &#226;&#381;&#164; <br /> Individual saturation curves &#239;&#172;?t eq 1 <br />                                                                                         &#226;&#710;&#8217;    (E + S + Kdapp)2 &#226;&#710;&#8217; 4ES &#226;&#381;&#166; /(2E)              }                  (9) <br />  <br />    v = VA / + K )                                            (1)           kburst maximal burst rate. dependence                                                                              burst amplitude L-histidine concentration &#239;&#172;?t V maximal velocity, substrate metal <br /> concentration, K Michaelis constant substrate                 =  0Kd)/(Kd +  )                                                    (10) <br /> (Km) constant metal (Kact). Individual saturation                 A0 maximal amplitude  absence L- <br /> curves showing substrate inhibition pattern &#239;&#172;?t eq 2                  histidine)   concentration L-histidine.                                                                              dependence kobs concentration L-histidine    v = VA /[K act + 1 + /K iapp)]                          (2)           described step binding mechanism, according eq 11 Kapp <br />           apparent inhibition constant  Inhibition                kobs = kon  + koff                                                      (11) <br /> data, recorded saturating concentrations ATP, PRPP, <br /> Mg2+, K+ variable concentration L-histidine, &#239;&#172;?t              kon second-order association rate constant koff eq 3                                                                      unimolecular dissociation rate constant. <br />  <br />    v = v0/[1 +  /IC50)nH ]                                   (3)           &#226;&#8211;&#160;    RESULTS <br />                                                                                 MtATP-PRT Puri&#239;&#172;?cation. hisG (rv2121) gene v0 uninhibited velocity, L-histidine                   sequence M. tuberculosis H37Rv codon-adapted concentration, IC50 concentration L-histidine necessary            E. coli chemically synthesized ligated pJ411, 50% inhibition, nH Hill number. Inhibition                nucleotide sequence con&#239;&#172;?rmed (DNA 2.0); 7.6 mg <br /> data showing linear, noncompetitive, uncompetitive patterns               MtATP-PRT puri&#239;&#172;?ed gram BL21(DE3)pLysS double-reciprocal plots &#239;&#172;?t eqs 4 5                            (pJ411::hisG), using single Ni-NTA chromatographic step. <br />    v = VA /[K (1 + /K  + 1 + /K ii)]                  (4)           Puri&#239;&#172;?ed MtATP-PRT subjected ESI-MS identi- <br />                                                                              &#239;&#172;?cation. puri&#239;&#172;?ed protein exhibited molecular mass                                                                              31,515.1 Da, experimental error    v = VA /[K + 1 + /K ii)]                                (5)           calculated molecular mass 31515.6 Da. result con&#239;&#172;?rms <br />                                                                              identity enzyme used following experiments. Kis Kii slope intercept inhibition <br />                                                                                 Oligomeric State MtATP-PRT. determined constants, respectively. NMR chemical shift data showing                                                                              apparent solution molecular mass MtATP-PRT using gel <br /> single titration event &#239;&#172;?t variation Henderson&#226;&#710;&#8217; <br />                                                                              &#239;&#172;?ltration, Sephadex S200 column. Figure 1 depicts <br /> Hasselbalch equation32 <br />                                                                              representative chromatograms obtained, showing    &#206;&#180; = (&#206;&#180;acid + &#206;&#180; base10 pH &#226;&#710;&#8217; pKa)/(1 + 10 pH &#226;&#710;&#8217; pKa)                         mycobacterial enzyme behaves single species solution, <br />                                                                (6) <br />                                                                              apparent molecular mass &#226;&#710;&#188;180 kDa. molecular &#206;&#180; instantaneous chemical shift parts million,            mass consistent hexameric form. repetition &#206;&#180;acid chemical shift protonated form, &#206;&#180;base             experiment lower concentrations protein yields chemical shift deprotonated form, pH                           result, indicating MtATP-PRT does display antilogarithm concentration protons, pKa                concentration-dependent change oligomeric state acid dissociation constant group titrated. Pre-                protein concentrations ranging 0.1 10 mg/mL. <br /> steady-state burst kinetic data &#239;&#172;?t eq 7                              Repetition experiment presence 2 mM L- <br />                                                                              histidine (Figure 1) showed overall result. Repetition <br />    Yt = e&#226;&#710;&#8217;kobst + vt + C                                     (7)           experiment presence ATP  &#239;&#172;?rst substrate                                                                              bind ATP-PRTs) did yield observable change Yt observed signal time t, amplitude             apparent molecular mass (data shown). results transient, kobs observed burst rate transient, v          indicate MtATP-PRT hexamer solution linear rate, C o&#239;&#172;&#8364;set linear phase.              oligomeric state in&#239;&#172;&#8218;uenced allosteric inhibitor dependence burst amplitude ATP concentration                       ATP, &#239;&#172;?rst substrate. conditions substrate enzyme concentration                       Steady-State Kinetics Inhibition Studies. MtATP- comparable described eq 833                                       PRT displays Michaelis&#226;&#710;&#8217;Menten kinetics substrates <br />                                                                       8030                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                                      Article <br />  <br />                                                                                    product, PR-ATP, potent inhibitor ATP-PRTs.34 <br />                                                                                    Interestingly, MtATP-PRT displays low activity neutral <br />                                                                                    acidic pH.  lowest pH used kinetic <br />                                                                                    studies 8.0. activity observed presence                                                                                    metal-chelating agent EDTA, indicating Mg2+ essential <br />                                                                                    activity rapidly dissociating enzyme (data <br />                                                                                    shown). Addition thiol reducing agent DTT did                                                                                    alter time course (data shown), indicating                                                                                    enzyme preparation did contain oxidized cysteine residues <br />                                                                                    disul&#239;&#172; bonds inhibit activity. <br />                                                                                       Apparent Km values obtained ATP (263 &#194;&#177; 63 &#206;&#188;M) <br />                                                                                    presence saturating concentrations PRPP                                                                                    MgCl2 200 mM KCl (Figure 2, panel) PRPP <br />                                                                                    (49 &#194;&#177; 6 &#206;&#188;M) presence saturating levels ATP, <br />                                                                                    MgCl2, KCl (Figure 2, middle panel). observed Figure 1. MtATP-PRT hexameric solution presence                   SeATP-PRT,22 high concentrations MgCl2 led inhibition <br /> absence L-histidine. Gel &#239;&#172;?ltration experiment illustrating lack          MtATP-PRT. Apparent Kact Ki values obtained change oligomeric state MtATP-PRT. Solid dashed lines                MgCl2 (1.9 &#194;&#177; 0.6 23.3 &#194;&#177; 8.6 mM, respectively) representative chromatographic traces MtATP-PRT (100 &#206;&#188;g)                    presence saturating concentrations substrates analyzed Sephacryl S200 absence presence 2 mM                 200 mM KCl (data shown). e&#239;&#172;&#8364;ect K+ rate L-histidine, respectively. experiments performed 20 mM <br /> Tris-HCl (pH 8) containing 100 mM NaCl. Results representative <br />                                                                                    MtATP-PRT saturable;  performed independent experiments.                                                   experiments 200 mM KCl (data shown). Steady-state <br />                                                                                    data summarized Table 1. <br />  <br /> (Figure 2). Time courses linear minutes (data                   Table 1. Steady-State Pre-Steady-State Kinetic shown), consistent previous observations                    Parameters MtATP-PRTa <br />                                                                                               parameter                            best &#239;&#172;?t                   equation <br />                                                                                         Vmax (s&#226;&#710;&#8217;1)                              0.31 &#194;&#177; 0.01                      1 <br />                                                                                         Km,ATP (&#206;&#188;M)                             263 &#194;&#177; 63                         1 <br />                                                                                         Km,PRPP (&#206;&#188;M)                            49 &#194;&#177; 6                           1 <br />                                                                                         Kact,Mg2+ (&#206;&#188;M)                          1900 &#194;&#177; 600                       2 <br />                                                                                         Ki,Mg2+ (&#206;&#188;M)                            23000 &#194;&#177; 900                      2 <br />                                                                                         IC50,L&#226;&#8364;&#8216;histidine (&#206;&#188;M)                   33 &#194;&#177; 3                           3 <br />                                                                                         Amax (&#206;&#188;M)                               7.8 &#194;&#177; 0.3                        8 <br />                                                                                         Kapp <br />                                                                                           d,ATP (&#206;&#188;M)                            47.2 &#194;&#177; 10.3                      8 <br />                                                                                         Kburst (s&#226;&#710;&#8217;1)                            0.67 &#194;&#177; 0.02                      9 <br />                                                                                         Kd,L&#226;&#8364;&#8216;histidine (&#206;&#188;M)                     27.9 &#194;&#177; 3.2                       10 <br />                                                                                         kon,L&#226;&#8364;&#8216;histidine (M&#226;&#710;&#8217;1 s&#226;&#710;&#8217;1)               4885 &#194;&#177; 717                       11 <br />                                                                                         koff,L&#226;&#8364;&#8216;histidine (s&#226;&#710;&#8217;1)                  0.95 &#194;&#177; 0.03                      11 <br />                                                                                                                                                                         Assays performed 50 mM bu&#239;&#172;&#8364;er, containing MgCl2 KCl,                                                                                    speci&#239;&#172;?ed values, 25 &#194;&#176;C. Materials Methods bu&#239;&#172;&#8364;ers <br />                                                                                    concentrations substrates, metals, L-histidine. <br />  <br />                                                                                       con&#239;&#172;?rmed inhibition MtATP-PRT L- <br />                                                                                    histidine determining IC50. seen Figure 2 <br />                                                                                     panel), preparation MtATP-PRT readily <br />                                                                                    inhibited L-histidine. experimental conditions,                                                                                    IC50 obtained L-histidine 33.3 &#194;&#177; 3.5 &#206;&#188;M Hill <br />                                                                                    number 1.5 (Table 1). obtain inhibition constants (Ki), <br />                                                                                    independent concentration enzyme, <br /> Figure 2. Steady-state kinetics MtATP-PRT inhibition L-              substrates, metal ions used,35 de&#239;&#172;?ne nature histidine. middle panels saturation curves                inhibition, performed single inhibition studies &#239;&#172;?xed <br /> ATP (&#226;&#8212;?) PRPP (&#226;&#8212;&#8249;), respectively. experiments                         saturating concentration substrate &#239;&#172;?xed variable <br /> performed 25 &#194;&#176;C, 50 mM Tris-HCl (pH 8.5) containing 7 mM                     concentrations second substrate. Inhibition L-histidine <br /> MgCl2 200 mM KCl. ATP concentration varied,                       versus PRPP linear noncompetitive (Figure 3), PRPP concentration 0.8 mM. PRPP concentration                     set lines intersecting left Y-axis double- varied, ATP concentration 1.6 mM. panel <br /> shows inhibition  single substrate concentration) MtATP- <br />                                                                                    reciprocal plot, Kii value 23.5 &#194;&#177; 6.5 &#206;&#188;M Kis value <br /> PRT L-histidine (&#226;&#8212;?). experiment performed 25 &#194;&#176;C,                 25.7 &#194;&#177; 12.8 &#206;&#188;M. Kii Kis values identical 50 mM Tris-HCl (pH 8.5) containing 7 mM MgCl2, 200 mM KCl, 1.6                     experimental error, L-histidine appears a&#239;&#172;&#402;nity <br /> mM ATP, 0.8 mM PRPP. Points data lines best &#239;&#172;?t eq 1                 enzyme presence absence PRPP.  middle panels) eq 2  panel). Results                       ATP concentration varied, L-histidine inhibition linear <br /> representative independent experiments.                                     uncompetitive (Figure 4), set parallel lines                                                                             8031                              dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                            Article <br />  <br />  <br />  <br />  <br /> Figure 3. Inhibition MtATP-PRT L-histidine vs PRPP.   Double-reciprocal plot illustrating linear noncompetitive inhibition pattern <br /> obtained varying concentration L-histidine &#239;&#172;?xed variable concentrations PRPP &#239;&#172;?xed saturating concentrations ATP, Mg2+, K+. Data obtained 50 mM Tris-HCl (pH 8.5) 25 &#194;&#176;C. Results representative independent experiments. Points data <br /> obtained 0 (&#226;&#8212;?), 15 (&#226;&#8212;&#8249;), 30 (&#226;&#8211;&#160;), 45 &#206;&#188;M L-histidine (&#226;&#8211;&#161;), error bars indicate standard deviation. Lines best &#239;&#172;?t entire <br /> data set eq 3. (B) Replot intercept data shown panel  , showing linear dependence inhibitor concentration. Replot slope data shown panel  , showing linear dependence inhibitor concentration. Points data, line linear <br /> regression data. <br />  <br />  <br />  <br />  <br /> Figure 4. Inhibition MtATP-PRT L-histidine vs ATP.   Double-reciprocal plot illustrating linear uncompetitive inhibition pattern <br /> obtained varying concentration L-histidine &#239;&#172;?xed variable concentrations ATP &#239;&#172;?xed saturating concentrations PRPP, Mg2+, K+. Data obtained 50 mM Tris-HCl (pH 8.5) 25 &#194;&#176;C. result representative independent experiments. Points data <br /> obtained 0 (&#226;&#8212;?), 15 (&#226;&#8212;&#8249;), 30 (&#226;&#8211;&#160;), 45 &#206;&#188;M L-histidine (&#226;&#8211;&#161;), error bars indicate standard deviation. Lines best &#239;&#172;?t entire <br /> data set eq 4. (B) Replot intercept data shown panel  showing linear dependence inhibitor concentration. Points data, line linear regression data. <br />  <br /> double-reciprocal plot, Kii value 27.9 &#194;&#177; 1.9 &#206;&#188;M.                STD experiments, recorded spectra L-histidine result indicates binding ATP essential inhibition            function pH determine ionization states L-histidine. Inhibition data summarized Table 2.                        experimental conditions pH-dependent changes    Ionic States L-Histidine Interaction                            chemical shifts sets protons L-histidine <br /> MtATP-PRT. de&#239;&#172;?ne ionic state L-histidine bound                       (Figure 5A). chemical shift protons in&#239;&#172;&#8218;uenced MtATP-PRT, &#239;&#172;?rst employed equilibrium &#239;&#172;&#8218;uorescence                         pH shown Figure 5B. Taken  results <br /> measurements. Unfortunately, binding L-histidine                       indicate experimental conditions protons C&#206;&#180;2- <br /> modestly alters intrinsic tryptophan &#239;&#172;&#8218;uorescence spectrum                  H, C&#206;&#181;1-H, C&#206;&#177;-H coupled report MtATP-PRT (data shown), precluding quantitative                         ionization imidazole ring. hand, protons <br /> analysis. alternative &#239;&#172;&#8218;uorescence, employed 1H                     C&#206;&#178;-H2 inform ionization &#206;&#177;-amino group. Data <br /> NMR characterize interaction. reasoned STD-                    shown Figure 5C Table 3 indicate L-histidine bound <br /> NMRa constitute simple e&#239;&#172;&#402;cient way                              MtATP-PRT subjected saturation transfer, monitoring ligand binding di&#239;&#172;&#8364;erent pH values.                    expected, process in&#239;&#172;&#8218;uenced pH. Speci&#239;&#172;?cally, <br />                                                                         8032                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                             Article <br />  <br /> Table 2. Steady-State Inhibition Constants MtATP-PRT L-Histidinea <br />              varied       inhibition <br />     pH     substrateb      patternc       Kii (&#206;&#188;M)          Kis (&#206;&#188;M) <br />     8.50     PRPP            NC           23.5   &#194;&#177;   6.5   25.7 &#194;&#177; 12.8 <br />     8.50     ATP             UC           27.9   &#194;&#177;   1.9   &#226;&#710;&#8217; <br />     8.00     ATP             UC            4.0   &#194;&#177;   0.4   &#226;&#710;&#8217; <br />     8.25     ATP             UC            7.9   &#194;&#177;   1.5   &#226;&#710;&#8217; <br />     8.50     ATP             UC           28.3   &#194;&#177;   2.1   &#226;&#710;&#8217; <br />     8.75     ATP             UC           26.8   &#194;&#177;   1.5   &#226;&#710;&#8217; <br />     9.00     ATP             UC           50.4   &#194;&#177;   5.5   &#226;&#710;&#8217; <br />     9.25     ATP             UC          109.4   &#194;&#177;   6.8   &#226;&#710;&#8217;  Assays performed 50 mM bu&#239;&#172;&#8364;er containing 7 mM MgCl2 200 <br /> mM KCl, speci&#239;&#172;?ed pH values, 25 &#194;&#176;C. Materials Methods bu&#239;&#172;&#8364;ers pH. bThe concentrations cosubstrates held &#239;&#172;?xed (0.8 mM PRPP 1.6 mM ATP). cNC, <br /> noncompetitive; UC, uncompetitive. <br />  <br /> saturation transfer neglible lower pH values (&lt;7.5) maximal high pH values (&#226;&#710;&#188;9), indicating neutral <br /> imidazole deprotonated &#206;&#177;-amino group favor binding. aliphatic protons appear pick saturation (Table 3), <br /> indicating looser contact protein, compared imidazole protons. <br />    pH&#226;&#710;&#8217;Rate Studies. investigate e&#239;&#172;&#8364;ect pH allosteric inhibition, determined Kii values L- <br /> histidine, varying ATP concentration &#239;&#172;?xed saturating <br /> concentration PRPP, various pH values. Figure 6 Table 2, L-histidine inhibition dependent pH, surprisingly, pH dependence inhibition opposite observed binding (inhibition weaker higher pH values). pH range 8&#226;&#710;&#8217;9.25, group titrated &#206;&#177;-amino group L-histidine,  likely observing direct e&#239;&#172;&#8364;ect protonation <br /> state inhibition. Unfortunately, low activity MtATP-PRT neutral acidic pH values, determine Kii values pH 8.0.  pKa values derived analysis, slope 1 obtained. result suggests deprotonation &#206;&#177;- <br /> amino group decreases inhibition potency. <br />    Pre-Steady-State Inhibition Studies. investigate elementary steps catalytic cycle directly <br /> a&#239;&#172;&#8364;ected L-histidine, studied inhibition MtATP-PRT <br /> using pre-steady-state kinetics (Table 1).  characterized kinetics absence inhibitor, determine                  Figure 5. Ionic states STD-NMR spectroscopy studies L- <br /> chemistry rate-limiting. Figure 7,                   histidine binding MtATP-PRT.   1H NMR spectrum L- <br /> multiple-turnover conditions progress curve MtATP-                       histidine 10 mM, 50 mM KPi (pH 8). asterisk indicates                                                                                 water signal. (B) Chemical shift dependence pH L-histidine. PRT displays burst kinetics. described single- <br />                                                                                 panel shows data ring protons, C&#206;&#180;2-H (&#226;&#8212;&#8249;) C&#206;&#181;1-H (&#226;&#8212;?). <br /> exponential increase followed steady-state phase (eq 7).                   panel shows data aliphatic protons, C&#206;&#177;-H (&#226;&#8211;&#161;) Burst kinetics diagnostic chemistry faster                     C&#206;&#178;-H (&#226;&#8211;&#160;). Experiments performed 50 mM sodium phosphate <br /> subsequent steps.36,37 particular case, product (PR-ATP)                bu&#239;&#172;&#8364;er indicated pH values, presence 0.4 mM L-histidine. <br /> formation directly observed,  buildup                     Symbols data, solid lines &#239;&#172;?ts eq 5. (C) pH <br /> product indicates slower steps chemical step. Burst                   dependence STD-NMR L-histidine 30 &#206;&#188;M MtATP-PRT. <br /> kinetics studied varying concentration ATP.                    Aromatic resonances (C&#206;&#180;2 C&#206;&#181;1) shown. Figure 8, quadratic dependence burst amplitude ATP concentration exper-                         mentioning  conditions, Y intercept imental conditions (Figure 8B, panel) amplitude                     plot burst dependence ATP concentration zero, <br /> maximum 7.8 &#194;&#177; 0.3 &#206;&#188;M (Table 3). value close                  indicating slow ATP dissociation. actual concentration active sites used (10 &#206;&#188;M),                             probed e&#239;&#172;&#8364;ect L-histidine, &#239;&#172;?xed saturating <br /> suggesting MtATP-PRT active catalysis.b                     ATP concentration. di&#239;&#172;&#8364;erent e&#239;&#172;&#8364;ects observed observed dependence kobs ATP concentration                      multiple-turnover conditions. marked e&#239;&#172;&#8364;ect burst &#239;&#172;?t quadratic equation (Figure 8B, panel),                   amplitude apparent increasing concentrations L- <br /> giving maximal kburst 0.67 &#194;&#177; 0.02 s&#226;&#710;&#8217;1 (Table 1). worth               histidine (Figure 9A,B). decrease burst amplitude <br />                                                                          8033                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                                    Article <br />  <br /> Table 3. Saturation Transfer Data L-Histidine MtATP-PRTa <br />                         % saturation transfer L-histidine protons <br />     pH           C&#206;&#177;-H            C&#206;&#178;-H2            C&#206;&#180;2-H            C&#206;&#181;1-H <br />     5.5            0               0                0                    0 <br />     6.0            0               0                0                    0 <br />     6.5            0               0                0                    0 <br />     7.5            0               0                0                    0 <br />     8.0            0               0               36.9                 40.4 <br />     8.5            0               0               81.6                 88.2 <br />     9.0            0               0              100                  100   Assays performed 50 mM sodium phosphate bu&#239;&#172;&#8364;er speci&#239;&#172;?ed <br /> pH values 25 &#194;&#176;C, containing 0.6 mM L-histidine 30 &#206;&#188;M HisG. <br />  <br />  <br />  <br />  <br />                                                                                       Figure 8. Pre-steady-state kinetics MtATP-PRT varying ATP <br />                                                                                       concentration.   Representative traces MtATP-PRT reaction <br /> Figure 6. pH dependence MtATP-PRT inhibition L-histidine. Kii <br />                                                                                       multiple-turnover conditions obtained di&#239;&#172;&#8364;erent concen- <br /> values obtained varying L-histidine concentration various <br />                                                                                       trations ATP &#239;&#172;?xed saturating concentrations PRPP &#239;&#172;?xed concentrations ATP &#239;&#172;?xed saturating concentrations                                                                                       metals. Gray lines represent data black lines best &#239;&#172;?t eq <br /> PRPP, MgCl2, KCl. experiments performed 25 &#194;&#176;C. <br />                                                                                       6. Data averages 10 traces. (B) Plot burst amplitude vs <br /> Symbols values obtained speci&#239;&#172;?ed pH values &#239;&#172;?tting data <br />                                                                                       ATP concentration   plot kobs vs ATP concentration eq 4; error bars represent standard error obtained &#239;&#172;?t                                                                                        . Symbols represent data solid lines best &#239;&#172;?t eqs 8 <br /> eq 4, solid line linear regression data. <br />                                                                                       9 burst amplitude burst rate dependencies, respectively. <br />                                                                                       Reactions conducted 50 mM Tris-HCl (pH 8.5), 150 mM <br />                                                                                       KCl, 10 mM MgCl2, 1.5 mM PRPP, 10 &#206;&#188;M MtATP-PRT, 25 <br />                                                                                       &#194;&#176;C. Results representative independent experiments. <br />  <br />                                                                                       chemical steps characterized decrease                                                                                       steady-state rate burst rate, respectively. Kd value                                                                                       27.9 &#194;&#177; 3.2 &#206;&#188;M obtained &#239;&#172;?tting data eq 10,                                                                                       good agreement Ki value obtained steady-state <br />                                                                                       kinetics. addition, linear decrease kobs observed (Figure <br />                                                                                       9C,D). <br />  <br />                                                                                       &#226;&#8211;&#160;    DISCUSSION <br />                                                                                          Oligomeric State MtATP-PRT. gel &#239;&#172;?ltration <br />                                                                                       experiments indicate MtATP-PRT mainly hexameric                                                                                       absence ligands presence L-histidine ATP, <br />                                                                                       pH 8. result appears contrast                                                                                       results obtained Cho colleagues,16 dimer&#226;&#710;&#8217;hexamer <br /> Figure 7. Stopped-&#239;&#172;&#8218;ow absorbance time course MtATP-PRT                         equilibrium, believe explained reaction. Representative trace MtATP-PRT progress curve (10 <br />                                                                                       experimental conditions used. worth mentioning &#206;&#188;M enzyme), multiple-turnover conditions, obtained saturating concentrations ATP PRPP, 50 mM Tris-HCl                          shift oligomeric state observed hexameric <br /> (pH 8.5) 25 &#194;&#176;C. gray line shows data, black line                       homologous enzyme S. enterica.20,23 interpretation represents best &#239;&#172;?t burst equation (eq 7). inset shows                  results lower pH values lead dissociation residuals &#239;&#172;?t burst equation.                                      MtATP-PRT dimers, observed Cho et al.  <br />                                                                                       evidence dimer represents kinetically <br />                                                                                       competent form MtATP-PRT, activity decreases <br /> indicates L-histidine a&#239;&#172;&#8364;ects MtATP-PRT largely                                drastically pH drops 8. Similar results trapping inactive complex. Slower product release                         recently reported ATP-PRT C. glutamicum.                                                                                8034                         dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                            Article <br />  <br />                                                                                 conformational changes invoked explain                                                                                 allosteric inhibition. <br />                                                                                    Inhibition MtATP-PRT L-Histidine. Steady-state <br />                                                                                 kinetic analysis indicates L-histidine inhibition versus PRPP <br />                                                                                 linear noncompetitive, Kis = Kii. equality                                                                                 inhibition constants indicates L-histidine                                                                                 a&#239;&#172;&#402;nity ATP-bound ATP-PRPP-bound enzyme <br />                                                                                 forms. L-Histidine inhibition versus ATP linear                                                                                 uncompetitive, indicating L-histidine binds MtATP- <br />                                                                                 PRT ATP present enzyme active site.                                                                                 results fully consistent allosteric inhibition <br />                                                                                 proposed basis structure. addition, <br />                                                                                 uncompetitive inhibition versus ATP agreement                                                                                 L-histidine&#226;&#710;&#8217;<span id='am-10' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-11' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span>AMP</span> ternary complex structure determined X- <br />                                                                                 ray crystallography.16 <br />                                                                                    Pre-steady-state kinetic analysis enzyme inhibition                                                                                 powerful approach determining step steps                                                                                 a&#239;&#172;&#8364;ected given inhibitor, applied study                                                                                 number systems, including DNA polymerase &#206;&#179;,38 HIV-1 <br />                                                                                 reverse transcriptase,39 D-3-phosphoglycerate dehydrogenase,40 <br />                                                                                 BACE.41 gather information L- <br />                                                                                 histidine inhibits MtATP-PRT, performed pre-steady-state <br />                                                                                 kinetic studies, using stopped-&#239;&#172;&#8218;ow absorbance, monitoring PR- <br />                                                                                 ATP formation. L-Histidine inhibition pre-steady-state <br />                                                                                 conditions complex, a&#239;&#172;&#8364;ecting multiple steps. dominant <br />                                                                                 e&#239;&#172;&#8364;ect observed decrease amplitude burst, <br /> Figure 9. Pre-steady-state kinetics MtATP-PRT inhibition L- <br />                                                                                 decrease burst steady-state rates. histidine.   Representative traces MtATP-PRT reaction            decrease burst amplitude indicates L-histidine inhibits <br /> pre-steady-state conditions various L-histidine concentrations,          MtATP-PRT trapping form catalytic &#239;&#172;?xed saturating concentrations ATP, PRPP, metals. Gray             inactive, severely slowing chemistry product <br /> lines represent data black lines best &#239;&#172;?ts eq 6. Data             release. basis results sequential ordered <br /> averages 10 traces. (B) Plot burst amplitude vs L-histidine           kinetic mechanismc previously proposed ATP-PRTs, concentration   plot kobs vs L-histidine concentration               inhibition using Scheme 3. Burton et al. elegantly <br />  . Symbols represent data solid lines best &#239;&#172;?ts eqs 10             demonstrated similar mechanism feedback allosteric 11 burst amplitude burst rate dependencies, respectively. <br /> Reactions conducted 50 mM Tris-HCl (pH 8.5), 150 mM <br />                                                                                 inhibition E. coli D-3-phosphoglycerate dehydrogenase <br /> KCl, 10 mM MgCl2, 1.5 mM PRPP, 4 mM ATP, 10 &#206;&#188;M MtATP-                       (PGDH) <span id='am-51' about='obo:IMR_0200453' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0001695 obo:IMR_0000001'><span id='am-52' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-53' property="rdfs:label" content="L-Serine" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasDbXref" content="KEGG:C00065" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:id" content="IMR:0200453" datatype="xsd:string"></span>L-serine</span>.40 important stress MtATP- <br /> PRT, 25 &#194;&#176;C. Results representative independent                    PRT PGDH structurally unrelated enzymes, experiments.                                                                    catalyze di&#239;&#172;&#8364;erent types chemistry distinct <br />                                                                                 substrates.  conservation allosteric <br />                                                                                 mechanism, e.g., sequestration enzyme&#226;&#710;&#8217;substrate&#226;&#710;&#8217; dimer present gel &#239;&#172;?ltration  pH 7.2),                   inhibitor complex nonproductive form, appears CgATP-PRT loses activity pH 8.25                               successful case convergent evolution. <br />    dimer&#226;&#710;&#8217;hexamer equilibrium does account                       basis steady-state data, extent L-histidine <br /> allosteric inhibition, mechanism envisioned.               inhibition maximal saturating ATP concentrations noteworthy mention Cho colleagues16 observed                   (uncompetitive kinetic pattern) independent large domain shift, domain III, dimeric form                          concentration PRPP [noncompetitive kinetic pattern (Kii = <br /> compared hexameric form. dimeric form                    Kis)]. Taken  results steady-state pre-steady- present experimental conditions, domain                    state experiments indicate k&#226;&#710;&#8217;6/k6 k&#226;&#710;&#8217;7/k7 ratios <br /> shift place, generating alternative hexamer,                (Scheme 3) similar, E&#226;&#710;&#8217;ATP&#226;&#710;&#8217; inhibited. Regardless conforma-                  histidine E&#226;&#710;&#8217;ATP&#226;&#710;&#8217;PRPP&#226;&#710;&#8217;histidine complexes tional change responsible L-histidine inhibition,                inactive forms MtATP-PRT. structural basis propose MtATP-PRT functional hexamer                           e&#239;&#172;&#8364;ect de&#239;&#172;?ned lack structural <br />  <br /> Scheme 3 <br />  <br />  <br />  <br />  <br />                                                                          8035                       dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry                                                                                                                                            Article <br />  <br /> information regarding complexes MtATP-PRT                       0.4 40 &#206;&#188;M, correlate maximal variation <br /> substrates products, L-histidine.                          expected L-histidine M. tuberculosis. <br />     Ionic States L-Histidine Bound ATP-PRT.                             ATP-PRT characterized regard <br /> de&#239;&#172;?nition ionic state L-histidine best binds             inhibition constants. Comparison value reported best inhibits MtATP-PRT essential step                        Lactococcus lactis ATP-PRT indicates L-histidine levels <br /> molecular description inhibition, paves way              &#239;&#172;&#8218;uctuate 10-fold bacteria, Ki 81 &#206;&#188;M rational approach target site. &#239;&#172;?rst analyzed                    determined, pH 8.42 S. enterica serovar Typhimurium, <br /> binding, using STD-NMR. pH dependence STD-                          intracellular concentration L-histidine shown vary <br /> NMR clearly demonstrates L-histidine binds better                      15 100 &#206;&#188;M, depending growth <br /> MtATP-PRT higher pH values. speci&#239;&#172;?cally, deproto-                      conditions.15 basis values, concentration <br /> nation &#206;&#177;-amino group L-histidine increases extent                L-histidine M. tuberculosis range saturation transfer, correlates increased level               Salmonella Lactococcus. binding. basis identity residues involved                 Chemical Mechanism. observations L-histidine binding, Asp218, Thr238, Ala273,                         regarding chemical mechanism MtATP-PRT.  <br /> tentatively assign e&#239;&#172;&#8364;ect titration &#206;&#177;-amino group                MtATP-PRT displays unusual pH dependence, L-histidine (pKa &#226;&#710;&#188; 9). result likely              observed homologous enzymes.25 MtATP- <br /> physiological importance, cytoplasm reach pH 9,                PRT inactive pH &#226;&#8240;&#164;7, active neutral alkaline pH hints potential mechanism preparing L-histidine                 values 9.5. basis alkaline pH dependence analogues bind tightly MtATP-PRT.                                      unknown, caused highly basic active site, <br />    kinetic results demonstrate L-histidine inhibition              bind phosphates substrates, stronger (lower Ki values) near pH 8. opposite result              missing protein partner, alter obtained binding indicates form L-histidine               acidic pH. best inhibits MtATP-PRT di&#239;&#172;&#8364;erent form L-                      Second, multiple-turnover experiments showed burst histidine best binds  IC50 measurements L-                 product formation, indicating step chemistry histidine inhibition di&#239;&#172;&#8364;erent pH values performed                 partially rate-limiting MtATP-PRT. Unfortunately, ATP-PRTs, &#239;&#172;?rst report pH                         studies ATP-PRTs pre-steady-state <br /> dependence Ki L-histidine ATP-PRT. Bearing                       conditions, slow product release shown mind IC50 values misleading                  ubiquitous trait phosphoribosyltransferases. account concentration enzyme, substrates                   example, quinolinate phosphoribosyltransferase saturation, inhibition type, , note inhibitory           shown display burst kinetics, indicating chemistry behavior seen MtATP-PRT appears follow                        rate-limiting relatively slow (kobs = kcat = 0.4 s&#226;&#710;&#8217;1).43 trend observed homologous enzymes S. enterica                    contrast, nicotinate phosphoribosyltransferase displayed burst C. glutamicum.23,25 Speci&#239;&#172;?cally, higher pH values decrease                 kinetics, indicating fast chemistry (kobs &#226;&#8240;&#165; 500 s&#226;&#710;&#8217;1) slow inhibitory e&#239;&#172;&#8364;ect L-histidine, appears                  product release (kcat = 1.2 s&#226;&#710;&#8217;1).44 <br /> correlates pKa &#206;&#177;-amino group. emphasize                        Summary. Results presented indicate active L- ionizable groups responsible transmission                histidine-inhibited MtATP-PRT hexameric solution. L- inhibitory signal allosteric site active site          Histidine inhibition noncompetitive versus PRPP certainly important, unfortunately,                     uncompetitive versus ATP. Inhibition MtATP-PRT L- <br /> observed narrow pH range                          histidine strongly in&#239;&#172;&#8218;uenced pH, reaching higher potency <br /> employed study catalysis inhibition.                                    closer physiological pH. Binding L-histidine displays    Finally, important explain &#226;&#8364;&#339;reverse                      opposite pH dependence observed inhibition, indicating <br /> protonation&#226;&#8364;? behavior likely unique L-histidine                 deprotonation &#206;&#177;-amino group increases level MtATP-PRT. Usually, allosteric regulation enzymes                    binding decreases level inhibition.  L- <br /> studied analysis binding inhibition, rarely             histidine binds inhibits MtATP-PRT neutral pH dependence investigated.                          imidazole ionized &#206;&#177;-amino &#206;&#177;-carboxyl groups. Pre- <br /> assumption dissociation constant (Kd) inhibition                  steady-state kinetic studies revealed step chemistry <br /> constant (Ki) allosteric inhibitors identical              partially rate-limiting L-histidine exerts inhibition <br /> oversimpli&#239;&#172;?cation. likely case dealing                  decreasing catalytically active MtATP-PRT inhibitors allosteric sites contain groups               (Scheme 3). ionization constants near neutrality. allosteric <br /> inhibitors discovered characterized, examples likely  <br />                                                                                &#226;&#8211;&#160;   AUTHOR INFORMATION <br />                                                                                Corresponding Author <br />     L-Histidine Biosynthesis M. tuberculosis.                                                                                *MRC National Institute Medical Research, Ridgeway, <br /> conclusions regarding L-histidine levels drawn                     Hill, London NW7 1AA, U.K. Telephone: +44 (0)20 8816 studies. Assuming ATP saturating concentration                  2358. Fax: +44 (0)20 8816 2730. E-mail: luiz.pedro@nimr.mrc. cell,d half-maximal inhibition 4 &#206;&#188;M                  ac.uk. <br /> L -histidine, pH 8. indicates physiological <br /> concentrations L-histidine varying                      Funding <br /> value able feedback control pathway. Speci&#239;&#172;?cally,                 Work L.P.S.d.C. laboratory funded MRC <br /> concentrations &#226;&#8240;&#164;0.4 &#206;&#188;M make MtATP-PRT                          (MC_UP_A253_1111). S.P. J.P.P. recipients active, conversely, concentrations L-histidine &#226;&#8240;&#165;40 &#206;&#188;M                Erasmus Fellowships, European Commission. inhibit MtATP-PRT shut L-histidine                    Notes <br /> biosynthesis M. tuberculosis.  range,                authors declare competing &#239;&#172;?nancial  <br />                                                                         8036                        dx.doi.org/10.1021/bi300808b | Biochemistry 2012, 51, 8027&#226;&#710;&#8217;8038 <br />  Biochemistry <br />  <br /> &#226;&#8211;&#160; <br />                                                                                                                                                              Article <br />  <br />     ACKNOWLEDGMENTS                                                                 (4) Cook, P. F., Cleland, W. W. (2007) Enzyme Kinetics                                                                                   Mechanism, Garland Science Publishing, New York. thank Dr. Steve Howell ESI-MS analysis MtATP-                             (5) Bearer, C. F., Neet, K. E. (1978) Threonine inhibition PRT NIMR&#226;&#8364;&#8482;s Large Scale Laboratory E. coli growth.                      aspartokinase-homoserine dehydrogenase Escherichia coli. slow <br /> thank Drs. Clarissa M. Czekster Rafael G. da Silva                        transient cooperativity inhibition aspartokinase activity. <br /> thoughtful discussions. NMR spectra recorded                      Biochemistry 17, 3523&#226;&#710;&#8217;3530. <br /> MRC Biomedical NMR Centre, NIMR, Hill (funded                               (6) Carvalho, L. P., Argyrou, , Blanchard, J. S. (2005) Slow- <br /> MRC Grant Aid U117533887).                                                     onset feedback inhibition: Inhibition Mycobacterium tuberculosis &#206;&#177;- <br />  <br />  <br /> &#226;&#8211;&#160; <br />                                                                                   isopropylmalate synthase <span id='am-92' about='obo:IMR_0200492' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0001695 obo:IMR_0000001'><span id='am-93' property="oboInOwl:hasDbXref" content="KEGG:C00123" datatype="xsd:string"></span><span id='am-94' property="rdfs:label" content="L-Leucine" datatype="xsd:string"></span><span id='am-95' property="oboInOwl:id" content="IMR:0200492" datatype="xsd:string"></span><span id='am-96' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>L-leucine</span>. J.  Chem. Soc. 127, 10004&#226;&#710;&#8217; <br />     ABBREVIATIONS                                                                 10005. <br />                                                                                     (7) Edfeldt, F. N., Folmer, R. H., Breeze,  L. (2011) Fragment <br /> ATP-PRT, ATP phosphoribosyltransferase; PR-ATP, 1-(5-                             screening predict druggability (ligandability) lead discovery <br /> phospho-&#206;&#177;-D-ribosyl)-ATP; PPi, inorganic pyrophosphate;                           success. Drug Discovery Today 16, 284&#226;&#710;&#8217;287. <br /> PRPP, 5-phospho-&#206;&#177;-D-ribosyl pyrophosphate; SDS&#226;&#710;&#8217;PAGE,                                (8) Surade, S., Blundell, T. L. (2012) Structural biology drug <br /> sodium dodecyl sulfate&#226;&#710;&#8217;polyacrylamide gel electrophoresis;                        discovery difficult targets: limits ligandability. Chem. Biol. 19, <br /> TEA, triethanolamine; BCA, bicinchoninic acid; BSA, bovine                        42&#226;&#710;&#8217;50. <br /> serum albumin; Tris, tris(hydroxymethyl)aminomethane; ESI-                          (9) Fenton,  W. (2012) Identification allosteric-activating drug <br />                                                                                   leads human liver pyruvate kinase. Methods Mol. Biol. 796, 369&#226;&#710;&#8217; <br /> MS, electrospray ionization mass spectrometry; HEPES, 4-(2- <br />                                                                                   382. <br /> hydroxyethyl)piperazine-1-ethanesulfonic acid; NMR, nuclear                         (10) Luo, L., Parrish, C. , Nevins, N., McNulty, D. E., Chaudhari, <br /> magnetic resonance; STD, saturation transfer di&#239;&#172;&#8364;erence;                            M., Carson, J. D., Sudakin, V., Shaw,  N., Lehr, R., Zhao, H., <br /> PIPES, 1,4-piperazinediethanesulfonic acid; TAPS, N-[tris-                        Sweitzer, S., Lad, L., Wood, K. W., Sakowicz, R., Annan, R. S., Huang, <br /> (hydroxymethyl)methyl]-3-aminopropanesulfonic acid; CHES,                         P. S., Jackson, J. R., Dhanak, D., Copeland, R. , Auger, K. R. <br /> 2-(cyclohexylamino)ethanesulfonic acid.                                           (2007) ATP-competitive inhibitors mitotic kinesin KSP  <br /> &#226;&#8211;&#160; <br />                                                                                   function allosteric mechanism. Nat. Chem. Biol. 3, 722&#226;&#710;&#8217;726. <br />      ADDITIONAL NOTES                                                               (11) Liu, S., Chang, J. S., Herberg, J. T., Horng, M. M., Tomich, P. K.,                                                                                 Lin,  H., Marotti, K. R. (2006) Allosteric inhibition   Saturation transfer di&#239;&#172;&#8364;erence NMR (STD-NMR) 1H                             Staphylococcus aureus D-alanine:D-alanine ligase revealed crystallo- <br /> NMR method developed monitoring interaction                            graphic studies. Proc. Natl. Acad. Sci. U.S  103, 15178&#226;&#710;&#8217;15183. <br /> small molecules proteins, resonance assign-                        (12) Ceccarelli, D. F., Tang, X., Pelletier, B., Orlicky, S., Xie, W., <br /> ments protein necessary.28,29 method, &#239;&#172;?rst                 Plantevin, V., Neculai, D., Chou, Y. C., Ogunjimi, , Al-Hakim, , <br /> spectrum protein ligand obtained, followed                        Varelas, X., Koszela, J., Wasney, G. , Vedadi, M., Dhe-Paganon, S., <br /> second spectrum radiofrequency ablated                            Cox, S., Xu, S., Lopez-Girona, , Mercurio, F., Wrana, J., Durocher, <br /> resonances protein spin di&#239;&#172;&#8364;usion                           D., Meloche, S., Webb, D. R., Tyers, M., Sicheri, F. (2011) bound ligand (saturation transfer). ligand                           allosteric inhibitor human Cdc34 ubiquitin-conjugating enzyme. <br /> equilibrium bound free states, signals                    Cell 145, 1075&#226;&#710;&#8217;1087. <br />                                                                                     (13) Sousa, M. C., Kessler, B. M., Overkleeft, H. S., McKay, D. B. <br /> perturbed, ones bound ligand.                          (2002) Crystal structure HslUV complexed vinyl sulfone spectra obtained, subtracted,                          inhibitor: corroboration proposed mechanism allosteric <br /> resulting di&#239;&#172;&#8364;erence spectrum reveals resonances                      activation HslV HslU. J. Mol. Biol. 318, 779&#226;&#710;&#8217;785. <br /> ligand a&#239;&#172;&#8364;ected, indicating direct contact protein.                       (14) Ames, B. N., Martin, R. G., Garry, B. J. (1961) step <br /> b <br />   amplitude burst observed pre-steady-state                      histidine biosynthesis. J. Biol. Chem. 236, 2019&#226;&#710;&#8217;2026. <br /> multiple-turnover conditions function factors:                      (15) Winkler, M. E. (1987) Biosynthesis Histidine. Escherichia rate chemical step relative rate product                     coli Salmonella typhimurium: Cellular Molecular Biology <br /> release, (ii) internal equilibrium constant chemical                  (Neidhardt, F. C., Ed.) pp 395&#226;&#710;&#8217;411, American Society step, active site, (iii) fraction active enzyme.37              Microbiology, Washington, DC. goal studies complete                       (16) Cho, Y., Sharma, V., Sacchettini, J. C. (2003) Crystal <br /> kinetic mechanism MtATP-PRT, did attempt                             structure ATP phosphoribosyltransferase Mycobacterium <br />                                                                                   tuberculosis. J. Biol. Chem. 278, 8333&#226;&#710;&#8217;8339. <br /> determine amplitude burst lower                          (17) Cho, Y., Ioerger, T. R., Sacchettini, J. C. (2008) Discovery <br /> concentration MtATP-PRT.                                                       novel nitrobenzothiazole inhibitors Mycobacterium tuberculosis <br /> c <br />  Scheme 3 shows sequential ordered kinetic mechanism,                         ATP phosphoribosyl transferase (HisG) virtual screening. J. binding ATP followed binding PRPP. Product                          Med. Chem. 51, 5984&#226;&#710;&#8217;5992. <br /> release shown ordered, PPi dissociating &#239;&#172;?rst                        (18) Griffin, J. E., Gawronski, J. D., Dejesus, M. , Ioerger, T. R., <br /> followed PR-ATP. kinetic mechanism observed                           Akerley, B. J., Sassetti, C. M. (2011) High-resolution phenotypic SeATP-PRT.19                                                                 profiling defines genes essential mycobacterial growth d                                                                                 <span id='am-87' about='obo:IMR_0200486' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-88' property="rdfs:label" content="Cholesterol" datatype="xsd:string"></span><span id='am-89' property="oboInOwl:hasDbXref" content="KEGG:C00187" datatype="xsd:string"></span><span id='am-90' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-91' property="oboInOwl:id" content="IMR:0200486" datatype="xsd:string"></span>cholesterol</span> catabolism. PLoS Pathog. 7, e1002251. <br />   concentration ATP M. tuberculosis unknown, cells typically contain 1 10 mM ATP. range                         (19) Parish, T. (2003) Starvation survival response Mycobacterium <br /> corresponds roughly 5&#226;&#710;&#8217;50 times Km ATP.                                 tuberculosis. J. Bacteriol. 185, 6702&#226;&#710;&#8217;6706. <br />  <br />  <br /> &#226;&#8211;&#160; <br />                                                                                     (20) Voll, M. J., Appella, E., Martin, R. G. (1967) Purification <br />                                                                                   composition studies phosphoribosyladenosine <span id='am-38' about='obo:IMR_0200358' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-39' property="rdfs:label" content="Triphosphate" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:id" content="IMR:0200358" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasDbXref" content="KEGG:C00536" datatype="xsd:string"></span>triphosphate</span>:- <br />     REFERENCES                                                                    pyrophosphate phosphoribosyltransferase, enzyme histidine <br />  (1) Pardee,  B., Yates, R.  (1956) Control pyrimidine                 biosynthesis. J. Biol. Chem. 242, 1760&#226;&#710;&#8217;1767. <br /> biosynthesis Escherichia coli feedback mechanism. J. Biol. Chem.            (21) Brashear, W. T., Parsons, S. M. (1975) Evidence 221, 757&#226;&#710;&#8217;770.                                                                     covalent intermediate a <br /> </body></html>